Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

07 Jun 2026
// REUTERS
https://www.reuters.com/legal/transactional/incyte-nears-up-2-billion-deal-blood-disorder-biotech-star-ft-reports-2026-06-07/

21 Apr 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-04-21/star-therapeutics-receives-fda-rare-pediatric-disease-and-breakthrough-therapy-designations-for-vga0

05 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251229847126/en/Star-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference-on-Monday-January-12

06 Dec 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251205981362/en/Star-Therapeutics-Presents-Interim-Data-from-Phase-12-Multidose-Study-of-VGA039-in-Von-Willebrand-Disease-Demonstrating-Substantial-Bleed-Reductions-in-All-Patients-at-ASH-Annual-Meeting

03 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251031148432/en/Star-Therapeutics-to-Present-Interim-Data-from-Phase-12-Multidose-Study-of-VGA039-in-von-Willebrand-disease-at-ASH-Annual-Meeting

30 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250929595423/en/Star-Therapeutics-Announces-Oversubscribed-%24125-Million-Series-D-Financing
ABOUT THIS PAGE